Ondansetron (Generic for Zofran ODT)

Introducing Ondansetron developed to the Zofran ODT standard—a selective 5-HT3 receptor antagonist formulated for rapid dissolution in the mouth. This innovative, orally disintegrating tablet provides fast onset of action to prevent chemotherapy-induced nausea and vomiting, ensuring improved gastrointestinal comfort and enhanced patient convenience.